FDA approves next-gen pulsed field ablation catheter for paroxysmal atrial fibrillation
Boston Scientific announced it received FDA approval for its navigation-enabled ablation catheter for the treatment of paroxysmal atrial fibrillation and 510(k) clearance for new imaging software for its pulsed field ablation system.The company announced the immediate commercial launch of its ablation catheter and imaging software after FDA approval and clearance (Farawave Nav and Faraview,